Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy

被引:18
|
作者
Grootjans, Willem [1 ,2 ]
Usmanij, Edwin A. [1 ]
Oyen, Wim J. G. [1 ,3 ,4 ]
van der Heijden, Erik H. F. M. [5 ]
Visser, Eric P. [1 ]
Visvikis, Dimitris [6 ]
Hatt, Mathieu [6 ]
Bussink, Johan [7 ]
de Geus-Oei, Lioe-Fee [1 ,2 ,8 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiol, POB 9600, NL-2300 RC Leiden, Netherlands
[3] Inst Canc Res, London, England
[4] Royal Marsden NHS Fdn Trust, London, England
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Med, Nijmegen, Netherlands
[6] INSERM, UMR 1101, Lab Traitement Informat Med LaTIM, Brest, France
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
[8] Univ Twente, MIRA Inst, Biomed Photon Imaging Grp, Enschede, Netherlands
关键词
Early response monitoring; Non-small cell lung cancer; Concomitant chemoradiochemotherapy; F-18-FDG PET/CT; Total lesion glycolysis; Automatic image segmentation; TARGET VOLUME DELINEATION; RADIOTHERAPY FDG-PET; F-18-FDG PET; PROGNOSTIC VALUE; DOSE-ESCALATION; SURVIVAL; FAILURE; IMPACT; NSCLC; AREAS;
D O I
10.1016/j.radonc.2016.04.039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: This study evaluated the use of total lesion glycolysis (TLG) determined by different automatic segmentation algorithms, for early response monitoring in non-small cell lung cancer (NSCLC) patients during concomitant chemoradiotherapy. Materials and methods: Twenty-seven patients with locally advanced NSCLC treated with concomitant chemoradiotherapy underwent F-18-fluorodeoxyglucose (FDG) PET/CT imaging before and in the second week of treatment. Segmentation of the primary tumours and lymph nodes was performed using fixed threshold segmentation at (i) 40% SUVmax (T40), (ii) 50% SUVmax (T50), (iii) relative-threshold-level (RTL), (iv) signal-to-background ratio (SBR), and (v) fuzzy locally adaptive Bayesian (FLAB) segmentation. Association of primary tumour TLG (TLGT), lymph node TLG (TLGLN), summed TLG (TLG(S) = TLG(T) + TLG(LN)), and relative TLG decrease (Delta TLG) with overall -survival (OS) and progression-free survival (PFS) was determined using univariate Cox regression models. Results: Pretreatment TLG(T) was predictive for PFS and OS, irrespective of the segmentation method used. Inclusion of TLG(LN) improved disease and early response assessment, with pretreatment TLG(S) more strongly associated with PFS and OS than TLG(T) for all segmentation algorithms. This was also the case for Delta TLG(S), which was significantly associated with PFS and OS, with the exception of RTL and T40. Conclusions: Delta TLG(S) was significantly associated with PFS and OS, except for RTL and T40. Inclusion of TLG(LN) improves early treatment response monitoring during concomitant chemoradiotherapy with FDG-PET. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:473 / 479
页数:13
相关论文
共 50 条
  • [21] Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review
    Lesueur, Paul
    Martel-Laffay, Isabelle
    Escande, Alexandre
    Kissel, Manon
    Locher, Chrystel
    Gervais, Radj
    Schott, Roland
    Vergnenegre, Alain
    Chouaid, Christos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (11) : 1159 - 1165
  • [22] Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer
    Nadiye Akdeniz
    Mehmet Küçüköner
    Muhammet Ali Kaplan
    Zuhat Urakçı
    Oğur Karhan
    Yasin Sezgin
    Erkan Bilen
    Senar Ebinç
    Fatma Teke
    Şahin Laçin
    Özkan Alan
    Özlem Ercelep
    Abdurrahman Işıkdoğan
    Perran Fulden Yumuk
    International Journal of Clinical Oncology, 2020, 25 : 2015 - 2024
  • [23] Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
    Tang, Yong
    Qiao, Guibin
    Xu, Enwu
    Xuan, Yiwen
    Liao, Ming
    Yin, Guilin
    ONCOTARGETS AND THERAPY, 2017, 10 : 4527 - 4534
  • [24] Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer
    Akdeniz, Nadiye
    Kucukoner, Mehmet
    Kaplan, Muhammet Ali
    Urakci, Zuhat
    Karhan, Ogur
    Sezgin, Yasin
    Bilen, Erkan
    Ebinc, Senar
    Teke, Fatma
    Lacin, Sahin
    Alan, Ozkan
    Ercelep, Ozlem
    Isikdogan, Abdurrahman
    Yumuk, Perran Fulden
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (12) : 2015 - 2024
  • [25] Early tumor shrinkage served as a prognostic factor for patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy
    Wei, Min
    Ye, Qingqing
    Wang, Xuan
    Wang, Men
    Hu, Yan
    Yang, Yonghua
    Yang, Jiyuan
    Cai, Jun
    MEDICINE, 2018, 97 (19)
  • [26] Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer
    Roengvoraphoj, Olarn
    Wijaya, Cherylina
    Eze, Chukwuka
    Li, Minglun
    Dantes, Maurice
    Taugner, Julian
    Tufman, Amanda
    Huber, Rudolf Maria
    Belka, Claus
    Manapov, Farkhad
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (02) : 107 - 115
  • [27] Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant
    MacRae, R
    Shyr, Y
    Johnson, D
    Choy, H
    RADIOTHERAPY AND ONCOLOGY, 2002, 64 (01) : 37 - 40
  • [28] Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Benekli, Mustafa
    Coskun, Ugur
    Sevinc, Alper
    Akmansu, Muge
    Yildiz, Ramazan
    Ozturk, Banu
    Yaman, Emel
    Kalender, Mehmet Emin
    Orhan, Okan
    Yamac, Deniz
    Uner, Aytug
    MEDICAL ONCOLOGY, 2010, 27 (01) : 152 - 157
  • [29] Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer
    Ali Osman Kaya
    Suleyman Buyukberber
    Mustafa Benekli
    Ugur Coskun
    Alper Sevinc
    Muge Akmansu
    Ramazan Yildiz
    Banu Ozturk
    Emel Yaman
    Mehmet Emin Kalender
    Okan Orhan
    Deniz Yamac
    Aytug Uner
    Medical Oncology, 2010, 27 : 152 - 157
  • [30] Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy
    Dang, Jun
    Li, Guang
    Zang, Shuang
    Zhang, Shuo
    Yao, Lei
    RADIATION ONCOLOGY, 2014, 9